Analysis: South Africa secures good prices for TB medicines, with one exception

An article published in Spotlight compares prices in recent South African Government tender for TB medicines versus global prices available via the Global Drug Facility. The article covers bedaquiline, delamanid, linezolid and rifapentine.

To read the full article, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By Spotlight

Published: Oct. 23, 2019, 1:03 a.m.

Last updated: Oct. 31, 2019, 1:08 a.m.

Tags: Treatment, Access

Print Share